Monetary costs of agitation in older adults with Alzheimer's disease in the UK: prospective cohort study

BMJ Open
Stephen MorrisGill Livingston

Abstract

While nearly half of all people with Alzheimer's disease (AD) have agitation symptoms every month, little is known about the costs of agitation in AD. We calculated the monetary costs associated with agitation in older adults with AD in the UK from a National Health Service and personal social services perspective. Prospective cohort study. London and the South East Region of the UK (LASER-AD study). 224 people with AD recruited between July 2002 and January 2003 and followed up for 54 months. The primary outcome was health and social care costs, including accommodation costs and costs of contacts with health and social care services. Agitation was assessed using the Neuropsychiatric Inventory (NPI) agitation score. After adjustment, health and social care costs varied significantly by agitation, from £29,000 over a 1 year period with no agitation symptoms (NPI agitation score=0) to £57,000 at the most severe levels of agitation (NPI agitation score=12; p=0.01). The mean excess cost associated with agitation per person with AD was £4091 a year, accounting for 12% of the health and social care costs of AD in our data, and equating to £2 billion a year across all people with AD in the UK. Agitation in people with AD represents a ...Continue Reading

References

Nov 1, 1975·Journal of Psychiatric Research·M F FolsteinP R McHugh
Dec 12, 2001·The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry·L S SchneiderJ A Lieberman
Sep 24, 2002·JAMA : the Journal of the American Medical Association·Constantine G LyketsosSteven DeKosky
Oct 29, 2004·Journal of Health Services Research & Policy·Julie Barber, Simon Thompson
Nov 16, 2005·The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry·Seung-Ho RyuGill Livingston
May 6, 2006·International Journal of Geriatric Psychiatry·Linus JönssonAnders Wimo
Dec 12, 2007·Archives of Neurology·Nikolaos ScarmeasYaakov Stern
Feb 4, 2009·International Journal of Geriatric Psychiatry·Matt ParadiseGill Livingston
May 18, 2011·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Anders GustavssonLinus Jönsson
Mar 22, 2012·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Brendan MulhernSube Banerjee
Mar 22, 2012·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Donna RowenJohn E Brazier
May 23, 2012·Health & Social Care in the Community·Hannah FairbrotherElizabeth Goyder
Feb 5, 2013·South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde·B D Schoub
Dec 3, 2014·The British Journal of Psychiatry : the Journal of Mental Science·Gill LivingstonClaudia Cooper

❮ Previous
Next ❯

Citations

Dec 24, 2015·Current Psychiatry Reports·Aaron M KoenigJoel E Streim
Nov 16, 2018·International Journal of Geriatric Psychiatry·Rachel HalpernMyrlene Sanon Aigbogun
Jun 26, 2018·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Myuri RuthirakuhanNathan Herrmann
Dec 5, 2019·Alzheimer's & Dementia : Translational Research & Clinical Interventions·Martin CloutierMyrlene Sanon Aigbogun
Feb 6, 2020·Journal of Geriatric Psychiatry and Neurology·Jeffrey Cummings
Apr 2, 2020·International Psychogeriatrics·Claire V BurleyHenry Brodaty
Dec 3, 2020·International Journal of Environmental Research and Public Health·Carolina Pinazo-ClapésAlicia Sales
Feb 13, 2021·The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry·John D OutenPaul B Rosenberg
Feb 19, 2021·Psychogeriatrics : the Official Journal of the Japanese Psychogeriatric Society·Romina Mouriz-CorbelleDavid Facal
Jul 13, 2021·Journal of Alzheimer's Disease : JAD·Eddie JonesJoseph Husbands

❮ Previous
Next ❯

Software Mentioned

DEMQOL

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Nihon rinsho. Japanese journal of clinical medicine
Atsushi Hachimori
Breastfeeding Medicine : the Official Journal of the Academy of Breastfeeding Medicine
Melissa Bartick
© 2021 Meta ULC. All rights reserved